Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
Leukemia
Novel Agents Will Completely Change CLL Treatment
Read More
Leukemia
Bendamustine Outperforms R-CHOP in NHL
Read More
Pediatric Cancer
Crizotinib Effective in Aggressive Pediatric Tumors
Caroline Helwick
Read More
Pipeline
The Oncology Drug Pipeline Robust with Novel Agents
Caroline Helwick
,
Wayne Kuznar
Read More
Payers' Perspectives
Payers Collaborate with Providers to Adopt Oncology Pathways, New Care Delivery Models
Rhonda Greenapple, MSPH
Read More
Family History of Cancer/Genetic Counseling Often Lacking for Patients First Presenting with Malignancy
Wayne Kuznar
Read More
For Advanced GIST, Regorafenib Shows Robust Effect
Read More
Cancer Screening Is Cost-Effective, Saves Lives
Read More
Cancer Therapies in Short Supply Prompt a Response at the Federal Level
Wayne Kuznar
Read More
High OOP Costs for Medicare Patients with Cancer
Mark Knight
Read More
1
2
3
4
Page 2 of 4
Results 11 - 20 of 33